Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cipla
Chinese Patent Office
Novartis
Cerilliant
Harvard Business School
Merck
Covington
Citi
Federal Trade Commission

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021625

« Back to Dashboard
NDA 021625 describes M.V.I. ADULT, which is a drug marketed by Hospira and is included in two NDAs. It is available from two suppliers. Additional details are available on the M.V.I. ADULT profile page.

The generic ingredient in M.V.I. ADULT is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k profile page.

Summary for NDA: 021625

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E','VITAMIN K') AND hsdb_d' at line 1
Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0